tiprankstipranks
Advertisement

DEUS - ETF AI Analysis

Compare

Top Page

DEUS

Xtrackers Russell US Multifactor ETF (DEUS)

Rating:71Outperform
Price Target:
DEUS, the Xtrackers Russell US Multifactor ETF, has a solid overall rating, helped by strong contributors like Flex and Western Digital, which show robust financial performance, positive earnings calls, and supportive technical trends that point to ongoing growth potential. Royalty Pharma also adds quality through strong profitability and strategic acquisitions. However, holdings such as McKesson and Verisign, which face leverage concerns, weaker technical signals, and valuation risks, slightly weigh on the fund’s rating, and investors should be aware that some positions carry higher debt and potential overvaluation risk.
Positive Factors
Broad Sector Diversification
The ETF spreads its investments across many sectors, which can help reduce the impact if any one industry struggles.
Generally Strong Top Holdings
Most of the largest positions have shown strong or steady performance this year, supporting the fund’s overall returns.
Low Expense Ratio
The fund charges a relatively low management fee, which helps investors keep more of their returns over time.
Negative Factors
Heavy U.S. Concentration
With almost all assets in U.S. stocks, the fund offers limited geographic diversification and is highly tied to the U.S. market.
Exposure to Some Weak Holdings
At least one top holding has shown weak performance this year, which can drag on the ETF’s results if it continues.
Moderate Fund Size
The ETF’s asset base is not very large, which could lead to lower trading volume and slightly wider bid-ask spreads for investors.

DEUS vs. SPDR S&P 500 ETF (SPY)

DEUS Summary

The Xtrackers Russell US Multifactor ETF (DEUS) tracks the Russell 1000 Comprehensive Factor Index, focusing on large U.S. companies but tilting toward stocks that look attractive on measures like value, quality, and price trends. It holds many well-known names such as McKesson and Cigna, and spreads investments across sectors like technology, health care, and financials. Someone might invest in DEUS to get broad U.S. stock market exposure with an added focus on potentially stronger companies, helping with diversification and long-term growth. A key risk is that it still moves with the overall stock market and can lose value during market downturns.
How much will it cost me?The Xtrackers Russell US Multifactor ETF (DEUS) has an expense ratio of 0.17%, meaning you’ll pay $1.70 per year for every $1,000 invested. This is lower than average for actively managed ETFs because it uses a multifactor strategy while keeping costs relatively low.
What would affect this ETF?The Xtrackers Russell US Multifactor ETF (DEUS) could benefit from positive trends in the U.S. economy, such as strong growth in large-cap sectors like technology and healthcare, which are key components of the fund. However, it may face challenges from rising interest rates or economic slowdowns, which could negatively impact sectors like financials and consumer cyclical stocks. Additionally, regulatory changes or shifts in market sentiment could influence the performance of its top holdings, such as Cardinal Health and McKesson.

DEUS Top 10 Holdings

DEUS leans into a U.S.-only mix of industrials and tech, and its recent story is being written by a handful of rising names. Flex, Western Digital, and Jabil have been doing the heavy lifting, with momentum helped by AI-driven demand and manufacturing strength. Marathon Petroleum is also adding some fuel to returns from the energy side. On the flip side, McKesson has been lagging and acting like a small anchor on performance, while steadier names like Cigna and Altria help smooth out the ride rather than drive big gains.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Flex1.31%$3.63M$55.69B247.11%
74
Outperform
McKesson1.05%$2.91M$94.62B7.67%
62
Neutral
Western Digital0.87%$2.42M$182.44B910.64%
77
Outperform
Altria Group0.83%$2.31M$119.25B20.28%
64
Neutral
Jabil0.71%$1.99M$39.76B118.85%
73
Outperform
Marathon Petroleum0.71%$1.97M$76.14B58.64%
66
Neutral
Cigna0.65%$1.81M$77.99B-6.11%
72
Outperform
Verisign0.64%$1.78M$25.44B0.00%
62
Neutral
TD SYNNEX Corporation0.61%$1.70M$22.28B127.54%
73
Outperform
Royalty Pharma0.60%$1.68M$31.84B57.49%
79
Outperform

DEUS Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
63.25
Positive
100DMA
62.19
Positive
200DMA
59.99
Positive
Market Momentum
MACD
0.59
Negative
RSI
66.29
Neutral
STOCH
87.47
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DEUS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 64.21, equal to the 50-day MA of 63.25, and equal to the 200-day MA of 59.99, indicating a bullish trend. The MACD of 0.59 indicates Negative momentum. The RSI at 66.29 is Neutral, neither overbought nor oversold. The STOCH value of 87.47 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DEUS.

DEUS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$276.45M0.17%
71
Outperform
$979.25M0.46%
74
Outperform
$955.05M0.25%
71
Outperform
$946.27M0.18%
72
Outperform
$936.68M0.25%
74
Outperform
$879.02M0.75%
71
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DEUS
Xtrackers Russell US Multifactor ETF
65.62
11.22
20.63%
MODL
VictoryShares WestEnd U.S. Sector ETF
SPHB
Invesco S&P 500 High Beta ETF
DSPY
Tema S&P 500 Historical Weight ETF Strategy
QLC
FlexShares US Quality Large Cap Index Fund
FTQI
First Trust Hedged BuyWrite Income ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement